Bicara Therapeutics BCAX Business Segments — Income Tax Expense (Benefit), Including Adjustments

Similar metrics at other companies

GBTGReportable Segment — Income Tax Expense (Benefit)

$10M-39.4%

PGNYReportable segment — Income Tax Expense (Benefit)

$12.65M+10.2%

TVTXReportable Segment — Income Tax Expense (Benefit)

-$120K-408%

PEBReportable Segment — Income Tax Expense (Benefit)

-$17K+99.5%

CELHReportable Segment — Income Tax Expense (Benefit)

$27.44M+65.5%

VGN

VGNTReportable Segment — Income tax (benefit) expense

$9M+131%

Questions, answered.

What is Bicara Therapeutics's business segments — income tax expense (benefit), including adjustments?

Bicara Therapeutics (BCAX) reported business segments — income tax expense (benefit), including adjustments of $52K in Q1 2026.

How has Bicara Therapeutics's business segments — income tax expense (benefit), including adjustments changed year-over-year?

Bicara Therapeutics's business segments — income tax expense (benefit), including adjustments decreased by 27.8% year-over-year, from $72K to $52K.

What is the long-term trend for Bicara Therapeutics's business segments — income tax expense (benefit), including adjustments?

Over 2 years (2023 to 2025), Bicara Therapeutics's business segments — income tax expense (benefit), including adjustments has grown at a 558.8% compound annual growth rate (CAGR), from $5K to $217K.

What does business segments — income tax expense (benefit), including adjustments mean?

This metric represents the total tax liability or benefit recognized by the company for its operations during the reporting period. It includes current and deferred tax provisions, reflecting the impact of tax regulations on the company's financial results.